DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET

被引：0
|
作者：
Werner, Jan-Michael [1 ,2 ]
Ceccon, Garry [1 ,2 ]
Weller, Johannes [3 ]
Schaub, Christina [3 ]
Tscherpel, Caroline [1 ,2 ]
Lohmann, Philipp [4 ]
Bauer, Elena [1 ,2 ]
Schaefer, Niklas [3 ]
Stoffels, Gabriele [4 ]
Kabbasch, Christoph [2 ,5 ]
Baues, Christian [2 ,6 ]
Marnitz, Simone [2 ,6 ]
Fink, Gereon R. [1 ,2 ]
Langen, Karl-Josef [4 ]
Herrlinger, Ulrich [3 ]
Galldiks, Norbert [1 ,2 ]
机构：
[1] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Univ Hosp Bonn, Dept Neurol, Div Clin Neurooncol, Bonn, Germany
[4] Res Ctr Juelich, Inst Neurosci & Med, Julich, Germany
[5] Univ Cologne, Fac Med, Dept Neuroradiol, Cologne, Germany
[6] Univ Cologne, Fac Med, Dept Radiat Oncol, Cologne, Germany
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NIMG-26
引用
收藏
页码：152 / 153
页数：3
相关论文
共 50 条
  • [41] Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
    Das, Sunit
    Sahgal, Arjun
    Perry, James R.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [42] RETROSPECTIVE ANALYSIS OF USING RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR CHINESE PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Wang, Yang
    Wu, Jingsong
    Qin, Zhiyong
    Wang, Enmin
    Yao, Yu
    Zhuang, Dongxiao
    Liang, Lipin
    Ni, Chunxia
    Lu, Peijiang
    Chen, Shu
    Li, Chao
    NEURO-ONCOLOGY, 2021, 23 : 72 - 72
  • [43] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Wei, Kuo-Chen
    Hsu, Peng-Wei
    Tsai, Hong-Chieh
    Lin, Ya-Jui
    Chen, Ko-Ting
    Toh, Cheng-Hong
    Huang, Hui-Lin
    Jung, Shih-Ming
    Tseng, Chen-Kan
    Ke, Yu-Xiong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Kuo-Chen Wei
    Peng-Wei Hsu
    Hong-Chieh Tsai
    Ya-Jui Lin
    Ko-Ting Chen
    Cheng-Hong Toh
    Hui-Lin Huang
    Shih-Ming Jung
    Chen-Kan Tseng
    Yu-Xiong Ke
    Scientific Reports, 11
  • [45] Hypofractionated radiotherapy with concurrent temozolomide chemotherapy in patients with newly diagnosed RPA class V glioblastoma multiforme: promising early results
    Ye, Jason C.
    Yondorf, Menachem
    Pannullo, Susan C.
    Boockvar, John A.
    Stieg, Philip E.
    Schwartz, Theodore H.
    Scheff, Ronald J.
    Parashar, Bhupesh
    Nori, Dattatreyudu
    Chao, K. S. Clifford
    Wernicke, A. Gabriella
    JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (01) : 19 - 27
  • [46] Late Radiation Outcomes of Patients with Newly Diagnosed Glioblastoma Treated with Accelerated Hyperfractionated Radiotherapy and Temozolomide
    Ergen, Sefika Arzu
    Meral, Rasim
    Altun, Musa
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2019, 34 (01): : 27 - 35
  • [47] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Saran, Frank
    Welsh, Liam
    James, Allan
    McBain, Catherine
    Gattamaneni, Rao
    Jefferies, Sarah
    Harris, Fiona
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Cseh, Agnieszka
    Brada, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 307 - 317
  • [48] Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme
    Barrié, M
    Couprie, C
    Dufour, H
    Figarella-Branger, D
    Muracciole, X
    Hoang-Xuan, K
    Braguer, D
    Martin, PM
    Peragut, JC
    Grisoli, F
    Chinot, O
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1177 - 1184
  • [49] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Frank Saran
    Liam Welsh
    Allan James
    Catherine McBain
    Rao Gattamaneni
    Sarah Jefferies
    Fiona Harris
    Karine Pemberton
    Jennifer Schaible
    Shaun Bender
    Agnieszka Cseh
    Michael Brada
    Journal of Neuro-Oncology, 2021, 155 : 307 - 317
  • [50] Phase II study of tarceva plus temodar during and following radiotherapy in patients newly diagnosed with glioblastoma or gliosarcoma
    Prados, Michael
    DeBoer, Rebecca
    Chang, Susan
    Butowski, Nicholas
    Burton, Eric
    Rabbitt, Jane
    Page, Margaretta
    Fedoroff, Anne
    Carliner, Hannah
    Parvataneni, Rupa
    Kivett, Valerie
    Sneed, Penny
    Kabuubi, Paul
    Larson, David
    Berger, Mitchel
    McDermott, Michael
    Lamborn, Kathleen
    Stokoe, David
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2007, 9 (04) : 528 - 528
12345